While the specific mechanism for these seemingly surprising results is unknown (though it might involve adaptive changes due to chronic KO, as has been hypothesised to be a factor for CB2 KO in AD models; see Section 6.3), these findings indicate the potential for context-dependent outcomes from CB2 modulation. The gene discussed is CNR2; the disease is Alzheimer disease.